Cargando…
Effect of Diquafosol on Hyperosmotic Stress-induced Tumor Necrosis Factor-α and Interleukin-6 Expression in Human Corneal Epithelial Cells
PURPOSE: Diquafosol is a pharmaceutical drug used for dry eye treatment with a novel mechanism of action. It is a purinergic P2Y2 receptor agonist that promotes the secretion of tears and healing of corneal epithelial wounds. However, its inhibitory effect on hyperosmotic stress-induced inflammation...
Autores principales: | Kim, Yeoun-Hee, Yang, In-Jun, Nguyen, Ly Thi Huong, Gum, Sang Il, Yu, Sung, Lee, Gwang Ja, Kim, Bo-Ae, Jung, Jae-Chang, Park, Young Jeung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010473/ https://www.ncbi.nlm.nih.gov/pubmed/32037744 http://dx.doi.org/10.3341/kjo.2019.0046 |
Ejemplares similares
-
Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress
por: Lee, Hyun Jung, et al.
Publicado: (2022) -
Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on human corneal epithelial cells
por: Lee, Jong Heon, et al.
Publicado: (2017) -
Formation of Non-Nucleoplasmic Proteasome Foci during the Late Stage of Hyperosmotic Stress
por: Lee, Jeeyoung, et al.
Publicado: (2021) -
Decrease in hyperosmotic stress–induced corneal epithelial cell apoptosis by L-carnitine
por: Khandekar, Neeta, et al.
Publicado: (2013) -
Alleviation of Endoplasmic Reticulum Stress Enhances Human Corneal Epithelial Cell Viability under Hyperosmotic Conditions
por: Guindolet, Damien, et al.
Publicado: (2022)